Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial

Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial

Introduction Sepsis and septic shock have mortality rates between 20% and 50%. In sepsis, the immune response becomes dysregulated, which leads to an imbalance between proinflammatory and anti-inflammatory mediators. When standard therapeutic measures fail to improve patients’ condition, additional...

Full description

Bibliographic Details
Main Authors: Péter Hegyi, Bálint Erőss, Noémi Zádori, Noémi Gede, Zsolt Márton, Anna Kanjo, Zsolt Molnar, Lajos Szakó, Tamás Kiss, Manu L N G Malbrain, Konstanty Szuldrzynski, Jakub Szrama, Krzysztof Kusza, Klaus Kogelmann
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/8/e050464.full

Internet

https://bmjopen.bmj.com/content/11/8/e050464.full

Similar Items